H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.However, an image was provided for review.The investigation of the reported event is currently underway.H10: d4 (expiry date: 10/2025).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device pending return.
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestar vascular stent products that are cleared in the us.The pro code and 510 k number for the lifestar vascular stent products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issues.Investigation summary: the stent delivery system was returned for evaluation and the stent was completely deployed and missing.The distal part of the delivery system stent sheath including sheath marker was broken, detached and missing.Provided images demonstrate the placed stent that is constricted towards one end; although the resolution of the image is poor it was assumed that the constriction is related to the detached and missing tip.The image also demonstrates an inserted guidewire that is not coaxial to the stent axis which reportedly was used for post dilation.The investigation is closed with confirmed results for break and detachment of the system tip.It was reported that a 6f/0.035" guidewire were used for access, there was tortuosity but a few calcified plaque, the lesion was pre-dilated and the system was successfully removed from the patient.Based on the available information and the evaluation of the provided photos, the investigation is closed with inconclusive results for partial deployment but confirmed for break and detachment.A definite root cause of the reported incident cannot be identified.Labeling review: in reviewing the relevant labeling it was found that the instructions for use sufficiently address the potential risks.Regarding warnings, the instructions for use states "should unusual resistance be felt at any time during the procedure, the entire system (introducer sheath or guiding catheter and stent delivery system) should be removed as a single unit".Regarding accessories, the instructions for use states "the 6f delivery system requires a minimum 8f guiding catheter, or a minimum 6f introducer sheath.Via the femoral route, insert a 0.035 inch (0.89 mm) guidewire under fluoroscopic guidance through the appropriate introducer sheath or guiding catheter and pass the lesion".The packaging pictograms indicate an introducer size of 6f and a 0.035" guidewire.With regards to the procedure, the instructions for use states "pre-dilatation of the stricture is recommended.Selection of an appropriately sized balloon dilatation catheter is left to the discretion of the treating physician".H10: b5, d4 (expiration date: 10/2025), g3, h6 (device) h11: h6 (method, result, conclusion) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
|